TNFRSF10B Gene

HGNC Family Tumor necrosis factor receptor superfamily (TNFRSF), CD molecules (CD)
Name tumor necrosis factor receptor superfamily, member 10b
Description The protein encoded by this gene is a member of the TNF-receptor superfamily, and contains an intracellular death domain. This receptor can be activated by tumor necrosis factor-related apoptosis inducing ligand (TNFSF10/TRAIL/APO-2L), and transduces an apoptosis signal. Studies with FADD-deficient mice suggested that FADD, a death domain containing adaptor protein, is required for the apoptosis mediated by this protein. Two transcript variants encoding different isoforms and one non-coding transcript have been found for this gene. [provided by RefSeq, Mar 2009]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nTNFRSF10B, more commonly known as death receptor 5 (DR5), is a key transmembrane receptor that, upon engagement by its ligand TRAIL (TNF‐related apoptosis‐inducing ligand), triggers apoptosis via the extrinsic pathway. DR5 signaling is initiated by the recruitment of adaptor molecules such as FADD and subsequent activation of caspase‑8, which orchestrates a caspase cascade leading to cell death. Moreover, DR5 can be upregulated and activated independently of extracellular ligand binding during persistent endoplasmic reticulum stress – a process regulated by stress inducible transcription factors (e.g. CHOP) – and even directly by interactions with misfolded proteins. This intrinsic “inner‐cell” activation integrates stress signals with the apoptotic machinery and sensitizes cells to death signals in various contexts, including those induced by interferon‐α and bile acids."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "7"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nStructural studies of DR5 have demonstrated that the receptor assembles as a trimer upon ligand binding, a configuration that is essential for the formation of the death‐inducing signaling complex (DISC). Detailed crystallographic and biophysical analyses have elucidated not only the extracellular binding interfaces by which TRAIL and agonistic ligands interact with DR5 but also revealed that the transmembrane helix itself can mediate higher‐order receptor clustering. This clustering, which is further modulated by specific interactions with adaptor molecules such as FADD, is critical for efficient caspase activation and subsequent induction of apoptosis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "8", "end_ref": "14"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn cancer cells, numerous therapeutic agents and strategies have been shown to modulate DR5 expression and activity. A variety of small molecules, natural products (such as resveratrol, luteolin, and quercetin), proteasome inhibitors, as well as engineered TRAIL or receptor‐selective variants and agonistic antibodies (for example, Apomab) have been reported to enhance DR5 expression and redistribute the receptor into lipid raft microdomains, thereby sensitizing resistant tumors to apoptosis. In addition, studies have uncovered that the antiapoptotic milieu—mediated by proteins like survivin or c‐FLIP—and specific microRNAs (for instance, miR‑1246) can suppress DR5 levels, thereby contributing to tumor cell survival. Thus, overcoming such regulatory blocks on DR5 function is emerging as a promising strategy to boost therapeutic efficacy against neoplastic cells."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "15", "end_ref": "31"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its central role in apoptosis induction and cancer therapeutics, DR5 is also implicated in various pathological and immunological contexts. Aberrant DR5 expression has been observed in settings such as chronic viral infections, autoimmune diseases, and inflammatory conditions, where it contributes to the regulation of immune cell homeostasis and the elimination of infected or aberrantly activated cells. For instance, enhanced DR5 on hepatocytes or synovial fibroblasts can predispose these cells to TRAIL‐mediated apoptosis—a mechanism that may underlie T cell tolerance in the liver during hepatitis, immune regulation in HIV infection, or joint destruction in rheumatoid arthritis. Moreover, defective DR5 signaling due to overexpression of inhibitory proteins like c‐FLIP has been linked to resistance in certain malignancies, underscoring its tumor‐suppressor functions."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "32", "end_ref": "40"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Masaya Shigeno, Kazuhiko Nakao, Tatsuki Ichikawa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.onc.1206139"}], "href": "https://doi.org/10.1038/sj.onc.1206139"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12642868"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12642868"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Mano Horinaka, Tatsushi Yoshida, Takumi Shiraishi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Luteolin induces apoptosis via death receptor 5 upregulation in human malignant tumor cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.onc.1208874"}], "href": "https://doi.org/10.1038/sj.onc.1208874"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16007131"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16007131"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Sook Kyung Park, Bob G Sanders, Kimberly Kline "}, {"type": "b", "children": [{"type": "t", "text": "Tocotrienols induce apoptosis in breast cancer cell lines via an endoplasmic reticulum stress-dependent increase in extrinsic death receptor signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Breast Cancer Res Treat (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10549-010-0786-2"}], "href": "https://doi.org/10.1007/s10549-010-0786-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20157774"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20157774"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Guangbo Liu, Ling Su, Xuexi Hao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Salermide up-regulates death receptor 5 expression through the ATF4-ATF3-CHOP axis and leads to apoptosis in human cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Mol Med (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1582-4934.2011.01401.x"}], "href": "https://doi.org/10.1111/j.1582-4934.2011.01401.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21801305"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21801305"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Makoto Edagawa, Junya Kawauchi, Manabu Hirata, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Role of activating transcription factor 3 (ATF3) in endoplasmic reticulum (ER) stress-induced sensitization of p53-deficient human colon cancer cells to tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis through up-regulation of death receptor 5 (DR5) by zerumbone and celecoxib."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M114.558890"}], "href": "https://doi.org/10.1074/jbc.M114.558890"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24939851"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24939851"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Min Lu, David A Lawrence, Scot Marsters, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Opposing unfolded-protein-response signals converge on death receptor 5 to control apoptosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Science (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/science.1254312"}], "href": "https://doi.org/10.1126/science.1254312"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24994655"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24994655"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Mable Lam, Scot A Marsters, Avi Ashkenazi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Misfolded proteins bind and activate death receptor 5 to trigger apoptosis during unresolved endoplasmic reticulum stress."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Elife (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7554/eLife.52291"}], "href": "https://doi.org/10.7554/eLife.52291"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31904339"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31904339"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "J Mongkolsapaya, J M Grimes, N Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Struct Biol (1999)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/14935"}], "href": "https://doi.org/10.1038/14935"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "10542098"}], "href": "https://pubmed.ncbi.nlm.nih.gov/10542098"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Lance R Thomas, Adrianna Henson, John C Reed, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Direct binding of Fas-associated death domain (FADD) to the tumor necrosis factor-related apoptosis-inducing ligand receptor DR5 is regulated by the death effector domain of FADD."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M401680200"}], "href": "https://doi.org/10.1074/jbc.M401680200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15173180"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15173180"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Almer M van der Sloot, Vicente Tur, Eva Szegezdi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Designed tumor necrosis factor-related apoptosis-inducing ligand variants initiating apoptosis exclusively via the DR5 receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0510187103"}], "href": "https://doi.org/10.1073/pnas.0510187103"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16731632"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16731632"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "C Adams, K Totpal, D Lawrence, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structural and functional analysis of the interaction between the agonistic monoclonal antibody Apomab and the proapoptotic receptor DR5."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Differ (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.cdd.4402306"}], "href": "https://doi.org/10.1038/sj.cdd.4402306"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18219321"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18219321"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Gelin Wang, Xiaoming Wang, Hong Yu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Small-molecule activation of the TRAIL receptor DR5 in human cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Chem Biol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nchembio.1153"}], "href": "https://doi.org/10.1038/nchembio.1153"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23292651"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23292651"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Verena Haselmann, Alexandra Kurz, Uwe Bertsch, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nuclear death receptor TRAIL-R2 inhibits maturation of let-7 and promotes proliferation of pancreatic and other tumor cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gastroenterology (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1053/j.gastro.2013.10.009"}], "href": "https://doi.org/10.1053/j.gastro.2013.10.009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24120475"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24120475"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Liqiang Pan, Tian-Min Fu, Wenbin Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Higher-Order Clustering of the Transmembrane Anchor of DR5 Drives Signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cell.2019.02.001"}], "href": "https://doi.org/10.1016/j.cell.2019.02.001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30827683"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30827683"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "E Mori, M Thomas, K Motoki, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Human normal hepatocytes are susceptible to apoptosis signal mediated by both TRAIL-R1 and TRAIL-R2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Differ (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.cdd.4401331"}], "href": "https://doi.org/10.1038/sj.cdd.4401331"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14576771"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14576771"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Qin He, Ying Huang, M Saeed Sheikh "}, {"type": "b", "children": [{"type": "t", "text": "Proteasome inhibitor MG132 upregulates death receptor 5 and cooperates with Apo2L/TRAIL to induce apoptosis in Bax-proficient and -deficient cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.onc.1207351"}], "href": "https://doi.org/10.1038/sj.onc.1207351"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14691451"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14691451"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Yan-Guo Ren, Klaus W Wagner, Deborah A Knee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differential regulation of the TRAIL death receptors DR4 and DR5 by the signal recognition particle."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Biol Cell (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1091/mbc.e04-03-0184"}], "href": "https://doi.org/10.1091/mbc.e04-03-0184"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15356269"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15356269"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Dominique Delmas, Cédric Rébé, Olivier Micheau, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.onc.1208086"}], "href": "https://doi.org/10.1038/sj.onc.1208086"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15480430"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15480430"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Robert F Kelley, Klara Totpal, Stephanie H Lindstrom, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Receptor-selective mutants of apoptosis-inducing ligand 2/tumor necrosis factor-related apoptosis-inducing ligand reveal a greater contribution of death receptor (DR) 5 than DR4 to apoptosis signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M410660200"}], "href": "https://doi.org/10.1074/jbc.M410660200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15520016"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15520016"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Fiona C Kimberley, Gavin R Screaton "}, {"type": "b", "children": [{"type": "t", "text": "Following a TRAIL: update on a ligand and its five receptors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Res (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.cr.7290236"}], "href": "https://doi.org/10.1038/sj.cr.7290236"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15538968"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15538968"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Konstantinos G Drosopoulos, Michael L Roberts, Lukas Cermak, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transformation by oncogenic RAS sensitizes human colon cells to TRAIL-induced apoptosis by up-regulating death receptor 4 and death receptor 5 through a MEK-dependent pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M412483200"}], "href": "https://doi.org/10.1074/jbc.M412483200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15757891"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15757891"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Fanny Rubio-Moscardo, David Blesa, Cinta Mestre, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Characterization of 8p21.3 chromosomal deletions in B-cell lymphoma: TRAIL-R1 and TRAIL-R2 as candidate dosage-dependent tumor suppressor genes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2005-05-2013"}], "href": "https://doi.org/10.1182/blood-2005-05-2013"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16051735"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16051735"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Jean-Philippe Herbeuval, Jakob Nilsson, Adriano Boasso, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differential expression of IFN-alpha and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0600363103"}], "href": "https://doi.org/10.1073/pnas.0600363103"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16632604"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16632604"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Wenshu Chen, Xia Wang, Jianguo Zhuang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Induction of death receptor 5 and suppression of survivin contribute to sensitization of TRAIL-induced cytotoxicity by quercetin in non-small cell lung cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Carcinogenesis (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/carcin/bgm133"}], "href": "https://doi.org/10.1093/carcin/bgm133"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17548900"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17548900"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Jin H Song, Karthikeyan Kandasamy, Andrew S Kraft "}, {"type": "b", "children": [{"type": "t", "text": "ABT-737 induces expression of the death receptor 5 and sensitizes human cancer cells to TRAIL-induced apoptosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M802511200"}], "href": "https://doi.org/10.1074/jbc.M802511200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18599488"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18599488"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Yaqin Zhang, Baolin Zhang "}, {"type": "b", "children": [{"type": "t", "text": "TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1541-7786.MCR-08-0313"}], "href": "https://doi.org/10.1158/1541-7786.MCR-08-0313"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19074831"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19074831"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Christopher C Valley, Andrew K Lewis, Deepti J Mudaliar, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces death receptor 5 networks that are highly organized."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M111.306480"}], "href": "https://doi.org/10.1074/jbc.M111.306480"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22496450"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22496450"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Mi Jin Yoon, You Jung Kang, In Young Kim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Monensin, a polyether ionophore antibiotic, overcomes TRAIL resistance in glioma cells via endoplasmic reticulum stress, DR5 upregulation and c-FLIP downregulation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Carcinogenesis (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/carcin/bgt137"}], "href": "https://doi.org/10.1093/carcin/bgt137"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23615398"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23615398"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Elena Strekalova, Dmitry Malin, David M Good, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Methionine Deprivation Induces a Targetable Vulnerability in Triple-Negative Breast Cancer Cells by Enhancing TRAIL Receptor-2 Expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-14-2792"}], "href": "https://doi.org/10.1158/1078-0432.CCR-14-2792"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25724522"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25724522"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Tianliang Li, Ling Su, Yuanjiu Lei, et al. "}, {"type": "b", "children": [{"type": "t", "text": "DDIT3 and KAT2A Proteins Regulate TNFRSF10A and TNFRSF10B Expression in Endoplasmic Reticulum Stress-mediated Apoptosis in Human Lung Cancer Cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M115.645333"}], "href": "https://doi.org/10.1074/jbc.M115.645333"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25770212"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25770212"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Dexiao Yuan, Jinping Xu, Juan Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Extracellular miR-1246 promotes lung cancer cell proliferation and enhances radioresistance by directly targeting DR5."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.9017"}], "href": "https://doi.org/10.18632/oncotarget.9017"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27129166"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27129166"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Shohei Koyama, Naoto Koike, Shinya Adachi "}, {"type": "b", "children": [{"type": "t", "text": "Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cancer Res Clin Oncol (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s004320100292"}], "href": "https://doi.org/10.1007/s004320100292"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11862476"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11862476"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Kimihisa Ichikawa, Weimin Liu, Martin Fleck, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TRAIL-R2 (DR5) mediates apoptosis of synovial fibroblasts in rheumatoid arthritis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.171.2.1061"}], "href": "https://doi.org/10.4049/jimmunol.171.2.1061"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12847280"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12847280"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Alexander Kotelkin, Elena A Prikhod'ko, Jeffrey I Cohen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Respiratory syncytial virus infection sensitizes cells to apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Virol (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/jvi.77.17.9156-9172.2003"}], "href": "https://doi.org/10.1128/jvi.77.17.9156-9172.2003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12915532"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12915532"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Ken H Young, Dennis D Weisenburger, Bhavana J Dave, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymphoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2007-02-072082"}], "href": "https://doi.org/10.1182/blood-2007-02-072082"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17881637"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17881637"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Haizhen Zhu, Huijia Dong, Erika Eksioglu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gastroenterology (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1053/j.gastro.2007.09.017"}], "href": "https://doi.org/10.1053/j.gastro.2007.09.017"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17983809"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17983809"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Travis W Day, Su Huang, Ahmad R Safa "}, {"type": "b", "children": [{"type": "t", "text": "c-FLIP knockdown induces ligand-independent DR5-, FADD-, caspase-8-, and caspase-9-dependent apoptosis in breast cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Pharmacol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bcp.2008.09.007"}], "href": "https://doi.org/10.1016/j.bcp.2008.09.007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18840411"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18840411"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Johannes Lemke, Andreas Noack, Dieter Adam, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TRAIL signaling is mediated by DR4 in pancreatic tumor cells despite the expression of functional DR5."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Mol Med (Berl) (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00109-010-0619-0"}], "href": "https://doi.org/10.1007/s00109-010-0619-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20354842"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20354842"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Dimitra Peppa, Upkar S Gill, Gary Reynolds, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Med (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1084/jem.20121172"}], "href": "https://doi.org/10.1084/jem.20121172"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23254287"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23254287"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Maria Rita Rippo, Simona Moretti, Silvia Vescovi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "FLIP overexpression inhibits death receptor-induced apoptosis in malignant mesothelial cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.onc.1208051"}], "href": "https://doi.org/10.1038/sj.onc.1208051"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15334061"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15334061"}]}]}]}
Synonyms TRICKB, KILLER, ZTNFR9, CD262, TRAIL-R2, TRAILR2, TRICK2A, DR5, TRICK2B, KILLER/DR5, TRICK2
Proteins TR10B_HUMAN
NCBI Gene ID 8795
API
Download Associations
Predicted Functions View TNFRSF10B's ARCHS4 Predicted Functions.
Co-expressed Genes View TNFRSF10B's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View TNFRSF10B's ARCHS4 Predicted Functions.

Functional Associations

TNFRSF10B has 16,770 functional associations with biological entities spanning 9 categories (molecular profile, organism, functional term, phrase or reference, chemical, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 127 datasets.

Click the + buttons to view associations for TNFRSF10B from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles tissues with high or low expression of TNFRSF10B gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles tissue samples with high or low expression of TNFRSF10B gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray tissue samples with high or low expression of TNFRSF10B gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq tissue samples with high or low expression of TNFRSF10B gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset.
Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles tissues with high or low expression of TNFRSF10B gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset.
Biocarta Pathways pathways involving TNFRSF10B protein from the Biocarta Pathways dataset.
BioGPS Cell Line Gene Expression Profiles cell lines with high or low expression of TNFRSF10B gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset.
BioGPS Human Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of TNFRSF10B gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset.
BioGPS Mouse Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of TNFRSF10B gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset.
Carcinogenome Chemical Perturbation Carcinogenicity Signatures small molecule perturbations changing expression of TNFRSF10B gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset.
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of TNFRSF10B gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
CCLE Cell Line Gene Expression Profiles cell lines with high or low expression of TNFRSF10B gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset.
CCLE Cell Line Gene Mutation Profiles cell lines with TNFRSF10B gene mutations from the CCLE Cell Line Gene Mutation Profiles dataset.
CCLE Cell Line Proteomics Cell lines associated with TNFRSF10B protein from the CCLE Cell Line Proteomics dataset.
CellMarker Gene-Cell Type Associations cell types associated with TNFRSF10B gene from the CellMarker Gene-Cell Type Associations dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of TNFRSF10B gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of TNFRSF10B gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
ChEA Transcription Factor Targets 2022 transcription factors binding the promoter of TNFRSF10B gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
CMAP Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of TNFRSF10B gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores cellular components containing TNFRSF10B protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 cellular components containing TNFRSF10B protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores cellular components co-occuring with TNFRSF10B protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with TNFRSF10B protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of TNFRSF10B gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
COSMIC Cell Line Gene Mutation Profiles cell lines with TNFRSF10B gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset.
CTD Gene-Chemical Interactions chemicals interacting with TNFRSF10B gene/protein from the curated CTD Gene-Chemical Interactions dataset.
CTD Gene-Disease Associations diseases associated with TNFRSF10B gene/protein from the curated CTD Gene-Disease Associations dataset.
dbGAP Gene-Trait Associations traits associated with TNFRSF10B gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset.
DeepCoverMOA Drug Mechanisms of Action small molecule perturbations with high or low expression of TNFRSF10B protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset.
DepMap CRISPR Gene Dependency cell lines with fitness changed by TNFRSF10B gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset.
DISEASES Experimental Gene-Disease Association Evidence Scores diseases associated with TNFRSF10B gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores dataset.
DISEASES Experimental Gene-Disease Association Evidence Scores 2025 diseases associated with TNFRSF10B gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores diseases co-occuring with TNFRSF10B gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 diseases co-occuring with TNFRSF10B gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
DisGeNET Gene-Disease Associations diseases associated with TNFRSF10B gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.
DisGeNET Gene-Phenotype Associations phenotypes associated with TNFRSF10B gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset.
DrugBank Drug Targets interacting drugs for TNFRSF10B protein from the curated DrugBank Drug Targets dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at TNFRSF10B gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of TNFRSF10B gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of TNFRSF10B gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
ESCAPE Omics Signatures of Genes and Proteins for Stem Cells PubMedIDs of publications reporting gene signatures containing TNFRSF10B from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset.
GAD Gene-Disease Associations diseases associated with TNFRSF10B gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.
GAD High Level Gene-Disease Associations diseases associated with TNFRSF10B gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset.
GDSC Cell Line Gene Expression Profiles cell lines with high or low expression of TNFRSF10B gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset.
GeneRIF Biological Term Annotations biological terms co-occuring with TNFRSF10B gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing TNFRSF10B from the GeneSigDB Published Gene Signatures dataset.
GEO Signatures of Differentially Expressed Genes for Diseases disease perturbations changing expression of TNFRSF10B gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of TNFRSF10B gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Kinase Perturbations kinase perturbations changing expression of TNFRSF10B gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of TNFRSF10B gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset.
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations transcription factor perturbations changing expression of TNFRSF10B gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Viral Infections virus perturbations changing expression of TNFRSF10B gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset.
GlyGen Glycosylated Proteins ligands (chemical) binding TNFRSF10B protein from the GlyGen Glycosylated Proteins dataset.
GO Biological Process Annotations 2015 biological processes involving TNFRSF10B gene from the curated GO Biological Process Annotations 2015 dataset.
GO Biological Process Annotations 2023 biological processes involving TNFRSF10B gene from the curated GO Biological Process Annotations 2023 dataset.
GO Biological Process Annotations 2025 biological processes involving TNFRSF10B gene from the curated GO Biological Process Annotations2025 dataset.
GO Cellular Component Annotations 2015 cellular components containing TNFRSF10B protein from the curated GO Cellular Component Annotations 2015 dataset.
GO Molecular Function Annotations 2015 molecular functions performed by TNFRSF10B gene from the curated GO Molecular Function Annotations 2015 dataset.
GO Molecular Function Annotations 2023 molecular functions performed by TNFRSF10B gene from the curated GO Molecular Function Annotations 2023 dataset.
GO Molecular Function Annotations 2025 molecular functions performed by TNFRSF10B gene from the curated GO Molecular Function Annotations 2025 dataset.
GTEx eQTL 2025 SNPs regulating expression of TNFRSF10B gene from the GTEx eQTL 2025 dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of TNFRSF10B gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of TNFRSF10B gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
GTEx Tissue Sample Gene Expression Profiles tissue samples with high or low expression of TNFRSF10B gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset.
GTEx Tissue-Specific Aging Signatures tissue samples with high or low expression of TNFRSF10B gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset.
Guide to Pharmacology Protein Ligands of Receptors ligands (protein) binding TNFRSF10B receptor from the curated Guide to Pharmacology Protein Ligands of Receptors dataset.
GWAS Catalog SNP-Phenotype Associations 2025 phenotypes associated with TNFRSF10B gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.
GWASdb SNP-Disease Associations diseases associated with TNFRSF10B gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset.
GWASdb SNP-Phenotype Associations phenotypes associated with TNFRSF10B gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset.
Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles cell lines with high or low expression of TNFRSF10B gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset.
HPA Cell Line Gene Expression Profiles cell lines with high or low expression of TNFRSF10B gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset.
HPA Tissue Gene Expression Profiles tissues with high or low expression of TNFRSF10B gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset.
HPA Tissue Protein Expression Profiles tissues with high or low expression of TNFRSF10B protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset.
HPA Tissue Sample Gene Expression Profiles tissue samples with high or low expression of TNFRSF10B gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset.
HPO Gene-Disease Associations phenotypes associated with TNFRSF10B gene by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset.
Hub Proteins Protein-Protein Interactions interacting hub proteins for TNFRSF10B from the curated Hub Proteins Protein-Protein Interactions dataset.
HuGE Navigator Gene-Phenotype Associations phenotypes associated with TNFRSF10B gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset.
InterPro Predicted Protein Domain Annotations protein domains predicted for TNFRSF10B protein from the InterPro Predicted Protein Domain Annotations dataset.
JASPAR Predicted Human Transcription Factor Targets 2025 transcription factors regulating expression of TNFRSF10B gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of TNFRSF10B gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
KEGG Pathways pathways involving TNFRSF10B protein from the KEGG Pathways dataset.
KEGG Pathways 2026 pathways involving TNFRSF10B protein from the KEGG Pathways 2026 dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of TNFRSF10B gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles cell lines with high or low expression of TNFRSF10B gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles cell lines with TNFRSF10B gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset.
KnockTF Gene Expression Profiles with Transcription Factor Perturbations transcription factor perturbations changing expression of TNFRSF10B gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset.
LINCS L1000 CMAP Chemical Perturbation Consensus Signatures small molecule perturbations changing expression of TNFRSF10B gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset.
LINCS L1000 CMAP CRISPR Knockout Consensus Signatures gene perturbations changing expression of TNFRSF10B gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset.
LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of TNFRSF10B gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
LOCATE Curated Protein Localization Annotations cellular components containing TNFRSF10B protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset.
LOCATE Predicted Protein Localization Annotations cellular components predicted to contain TNFRSF10B protein from the LOCATE Predicted Protein Localization Annotations dataset.
MiRTarBase microRNA Targets microRNAs targeting TNFRSF10B gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset.
MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations gene perturbations changing expression of TNFRSF10B gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset.
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles drug perturbations changing expression of TNFRSF10B gene from the NIBR DRUG-seq U2OS MoA Box dataset.
OMIM Gene-Disease Associations phenotypes associated with TNFRSF10B gene from the curated OMIM Gene-Disease Associations dataset.
PANTHER Pathways pathways involving TNFRSF10B protein from the PANTHER Pathways dataset.
Pathway Commons Protein-Protein Interactions interacting proteins for TNFRSF10B from the Pathway Commons Protein-Protein Interactions dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of TNFRSF10B gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations gene perturbations changing expression of TNFRSF10B gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PFOCR Pathway Figure Associations 2023 pathways involving TNFRSF10B protein from the PFOCR Pathway Figure Associations 2023 dataset.
PFOCR Pathway Figure Associations 2024 pathways involving TNFRSF10B protein from the Wikipathways PFOCR 2024 dataset.
PID Pathways pathways involving TNFRSF10B protein from the PID Pathways dataset.
Reactome Pathways 2014 pathways involving TNFRSF10B protein from the Reactome Pathways dataset.
Reactome Pathways 2024 pathways involving TNFRSF10B protein from the Reactome Pathways 2024 dataset.
Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of TNFRSF10B gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset.
Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of TNFRSF10B gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset.
Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of TNFRSF10B gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset.
Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles cell types and tissues with high or low DNA methylation of TNFRSF10B gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset.
Roadmap Epigenomics Cell and Tissue Gene Expression Profiles cell types and tissues with high or low expression of TNFRSF10B gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at TNFRSF10B gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of TNFRSF10B gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of TNFRSF10B gene from the RummaGEO Gene Perturbation Signatures dataset.
Sanger Dependency Map Cancer Cell Line Proteomics cell lines associated with TNFRSF10B protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset.
Sci-Plex Drug Perturbation Signatures drug perturbations changing expression of TNFRSF10B gene from the Sci-Plex Drug Perturbation Signatures dataset.
Tabula Sapiens Gene-Cell Associations cell types with high or low expression of TNFRSF10B gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset.
Tahoe Therapeutics Tahoe 100M Perturbation Atlas drug perturbations changing expression of TNFRSF10B gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
TargetScan Predicted Conserved microRNA Targets microRNAs regulating expression of TNFRSF10B gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset.
TargetScan Predicted Nonconserved microRNA Targets microRNAs regulating expression of TNFRSF10B gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset.
TCGA Signatures of Differentially Expressed Genes for Tumors tissue samples with high or low expression of TNFRSF10B gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores tissues with high expression of TNFRSF10B protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 tissues with high expression of TNFRSF10B protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores tissues with high expression of TNFRSF10B protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 tissues with high expression of TNFRSF10B protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores tissues co-occuring with TNFRSF10B protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with TNFRSF10B protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.
WikiPathways Pathways 2014 pathways involving TNFRSF10B protein from the Wikipathways Pathways 2014 dataset.
WikiPathways Pathways 2024 pathways involving TNFRSF10B protein from the WikiPathways Pathways 2024 dataset.